Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981356 · ClinicalTrials.gov registry record · Early Phase 1
Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis
A Early Phase 1 study of Psychotic Disorders, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01981356: Completed Early Phase 1 study of Psychotic Disorders, sponsored by VA Office of Research and Development.
NCT01981356 is a Early Phase 1 study of Psychotic Disorders that has completed, run by VA Office of Research and Development. The registered enrollment target is 18 participants, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01981356, a Early Phase 1 study of Psychotic Disorders, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a substantial need for enhancing the efficacy and effectiveness of Veterans Health Administration (VHA) inpatient services for psychosis and tailoring them to support recovery. The proposed pilot study will explore whether Acceptance and Commitment Therapy (ACT), a recovery-oriented, evidence-based inpatient treatment, is a feasible, acceptable, safe, and effective adjunct for the inpatient treatment of Veterans with psychosis at a single VHA site. Additionally, an evaluation of barriers and facilitators to future implementation will be conducted. If promising, the data gained from the proposed study will support future evaluation, implementation and dissemination efforts that have the potential to improve inpatient treatment for psychosis and recovery, and thus, the lives of Veterans, while reducing costs for VHA.
Conditions Studied
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy
- OTHER Treatment as Usual (TAU)
Study Locations (1)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01981356
The ClinicalTrials.gov registry entry for NCT01981356 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (93% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psychotic Disorders appearing as the primary indexed condition, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.
NCT01981356 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01981356 about?
NCT01981356 is a clinical study titled "Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis". There is a substantial need for enhancing the efficacy and effectiveness of Veterans Health Administration (VHA) inpatient services for psychosis and tailoring them to support recovery. The proposed pilot study will explore whether Acceptance and Commitment Therapy (ACT), a recovery-oriented, eviden...
What is the current status of trial NCT01981356?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 18 participants. The study started on 2014-09. Estimated completion is 2015-04.
What conditions does trial NCT01981356 study?
This clinical trial studies the following conditions: Psychotic Disorders.
What interventions are being tested in trial NCT01981356?
The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Treatment as Usual (TAU) (OTHER).
Who is sponsoring clinical trial NCT01981356?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01981356 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychotic Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
-
A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences
RECRUITING · NA
-
Racial Disparities in the Expression of Paranoia
RECRUITING · NA
-
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
RECRUITING · NA
-
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
RECRUITING · NA
-
CBT-CP for Veterans With SMI
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.